Aptose Biosciences Inc. secured $4.43 million in funding through a registered direct offering for working capital and general corporate use.

Aptose Biosciences Inc. has completed a registered direct offering, raising approximately $4.43 million by selling common shares at $1.15 each, as well as issuing series A and B warrants. The funding is intended for working capital and general corporate use.